Finally, they selected three of these markers (the genes HS3ST2, SLIT2 and SEPTIN9) for combination with the FGFR3 mutations in a logistic regression model, obtaining a sensitivity of 94.5% (96% in high-grade tumours) and a specificity of 75.9%. The gene discussed is HS3ST2; the disease is neoplasm.